Nektar Therapeutics Reports First Quarter 2025 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 41.80 -1.78 (4.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.58 | 52 Week High | $19.98 | |||
| Open | $43.50 | 52 Week Low | $10.52 | |||
| Day High | $43.50 | P/E | N/A | |||
| Day Low | $41.66 | EPS | $-1.45 | |||
| Volume | 295,965 | |||||
